A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

Author: Dahlöf Carl   Jones Martin   Davis Kim   Loftus Jane   Salonen Reijo  

Publisher: Springer Publishing Company

ISSN: 1129-2369

Source: The Journal of Headache and Pain, Vol.5, Iss.2, 2004-08, pp. : 115-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next